Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01541345
Other study ID # 2012DR2009
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date February 2011
Est. completion date June 4, 2019

Study information

Verified date November 2021
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Since there are no clinical studies available comparing the gold standard (autogenous bone graft plus resorbable membrane) to the promising combination of xenogenic bone graft loaded with rhBMP-2 in combination with a collagen membrane for localized ridge augmentation, the present exploratory study has been designed. The aim of the present study is therefore to test whether or not the application of a xenogenic bone block loaded with rhBMP-2 will results in clinically, radiographically and histologically similar outcomes as the gold standard (autogenous bone block) for the regeneration of chronic ridge defects. The investigators expect that there is no difference in bone quantity and quality between the two methods and that the use of the test treatment will be more user and patient friendly according to the patient perception/acceptance since no second surgical site will be necessary as well as cause less complications.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date June 4, 2019
Est. primary completion date April 25, 2014
Accepts healthy volunteers No
Gender All
Age group 20 Years to 75 Years
Eligibility Inclusion Criteria: - requiring implant therapy for the reconstruction of 1 to 4 missing teeth - revealing insufficient bone volume for implant placement (cases where less than 50% of the implant surface would be surrounded by native bone) requiring bone augmentation procedure Exclusion Criteria: - Medication with a contraindication for implant therapy - Previous administration of InductOs - Skeletal immaturity - Any active malignancy or patient undergoing treatment for a malignancy - An active infection at the operative site - Persistent compartment syndrome or neurovascular residua of compartment syndrome - Pathological fractures such as those observed in (but not limited to) Paget's disease or in metastatic bone - Contraindications to the class of drugs under study, e.g. known hypersensitivity or allergy to class of drugs or the investigational product, - Contraindications on ethical grounds, - Pregnancy, - Intention to become pregnant during the course of the study, - Breast feeding, - Treatment with other investigational products, - Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc), - Known or suspected non-compliance, drug or alcohol abuse, - Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia or confusional state of the subject, - Participation in another study with investigational drug within the 30 days preceding and during the present study, - Previous enrolment into the current study, - Enrolment of the investigator, his/her family members, employees and other dependent persons, - Patients where autogenous bone cannot be harvested.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Autogenous bone graft
Bone augmentation will be performed using autogenous bone from the retromolar or chin area followed by a fixation with titanium screws at the recipients site; filled with deproteinized bovine bone mineral (DBBM) particles (Bio-Oss®, Geistlich Pharma AG, Wolhusen, Switzerland) and covered with a collagen membrane (Bio-Gide®, Geistlich Pharma AG, Switzerland)
Drug:
InductOs
CE-marked medical device Bio-Oss Spongiosa Block® (xenogenic bone) loaded with InductOs® (1.5 mg Dibotermin alfa / ml) covered with Bio-Gide® (collagen membrane). One time application at augmentation surgery.
Procedure:
Augmentation surgery
CE-marked medical device Bio-Oss Spongiosa Block® (xenogenic bone) loaded with InductOs® (1.5 mg Dibotermin alfa / ml) covered with Bio-Gide® (collagen membrane)

Locations

Country Name City State
Austria Department of Oral Surgery & Radiology, Dental School, Medical University of Graz Graz
Switzerland Center of Dental Medicine Clinic of Reconstructive Dentistry Zurich

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Countries where clinical trial is conducted

Austria,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bone quality/quantity Bone quantity at 4 months after augmentation surgery, measured manually by ridge measurements and volumetrically on the basis of optical impressions and radiological assessment (X-ray and cone beam CT). Bone quality at 4 months after augmentation surgery, measured by histological assessment (yields different proportion per patient). 4 month after augmentation surgery
Secondary Complications Complications (soft tissue, sensitivity) measured at suture removal (8 days after augmentation surgery) and 4 months after augmentation surgery. Any adverse events will be recorded for the treatment period from visit 1 to 4. 8 days and 4 month after augmentation surgery
Secondary Bone quantity Bone quantity measured at screening, augmentation surgery, suture removal, and during follow-up at screening, augmentation surgery, suture removal, and during follow-up
Secondary Patient's perception/acceptance Patient's perception/acceptance (visual analogue scale VAS) measured at suture removal (8 days after augmentation surgery) 8 days after augmentation surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06007365 - Post Market Clinical FoIIow up (PMCF) Medical Device (MD) of Z-Systems Monotype Zirconia Dental Product: Z5m Dental Implants Registry
Completed NCT05350293 - Evaluation of the Abutment Type Following Oral Implants in Terms of the Surrounding Bone Height N/A
Completed NCT05359549 - Dental Implant Treatment for Two Adjacent Teeth in the Maxillary Aesthetic Region: an Evaluation After 10 Years
Completed NCT05650099 - Peri-implant Health of Dental Implants in the Posterior Region; an Evaluation After 10 Years
Completed NCT02239718 - Novel Use of 2-unit Cantilever Resin-bonded Bridges for Replacing Missing Molar Teeth - a Randomized Clinical Trial N/A
Recruiting NCT04581304 - The Use of Bio-Oss Collagen for Sinus Augmentation Using the Transcrestal Approach. N/A
Not yet recruiting NCT06033989 - Clinical and Radiographic Evaluation of the Effect of Hyaluronic Acid Surface Treatment Versus Sandblasted Acid Etched on Stability of Delayed Dental Implant in Posterior Maxilla. N/A
Completed NCT06178796 - Evaluation of the Effect of the Gap Between Bone and Implant Surface on the Implants Stability N/A
Recruiting NCT05649085 - Evaluation of Single-unit Implant-supported Prostheses Survival Using CoCr Prosthetic Abutments: Prospective Observational Study
Completed NCT02123420 - Platform Switching vs Regular Platform Implants. One Year Results From a RCT N/A
Active, not recruiting NCT05362591 - Anterior Resin Bonded Restorations for Adolescent N/A
Active, not recruiting NCT04378140 - Retention and Durability of the Anterior Zirconia Wing Bridge
Completed NCT01953991 - OHQoL With Removable Partial Dentures; a Pilot Study N/A
Active, not recruiting NCT01229995 - Randomized Controlled Clinical Trial of CAD/CAM and Conventionally Fabricated Singl Implant Abutments. N/A
Recruiting NCT04908618 - The Accuracy of Conventional Versus Digital Implant Impression Techniques N/A
Completed NCT05476848 - Relationship Between Oral Findings and Salivary Factors in Sars-Cov-2 Patients N/A
Completed NCT05403099 - Effect of Topical Application of Hyaluronic Acid on Stability of Immediate Loading Dental Implant in Posterior Maxilla N/A
Completed NCT03198520 - REFRAME RPD Post-Market Clinical Study N/A
Active, not recruiting NCT06334081 - Different Surgical Drilling Protocols in Posterior Maxilla N/A
Completed NCT03877419 - Comparison of Different Drilling Speed to Classify Bone Quality by Tactile Sensation on a Saw Bone Model